The independent source for health policy research, polling, and news.
KFF Health News’ coverage of women’s reproductive health care issues is supported in part by Arnold Ventures.
181 - 200 of 292 Results
Laws granting rights to unborn children have spread in the decades since the U.S. and Missouri supreme courts allowed Missouri’s definition of life as beginning at conception to stand. Now, a wrongful death lawsuit involving a workplace accident shows how sprawling those laws — often intended to curb abortion — have become.
The recently ended legislative session was marked by Medicaid reimbursement hikes, abortion restrictions, anti-LGBTQ+ statutes, behavioral health spending, and workforce and insurance measures.
New York and California have passed laws requiring disclosure of ingredients on menstrual product packaging. Advocates want more transparency across the U.S.
At least two Idaho hospitals are ending labor and delivery services, with one citing the state’s “legal and political climate” and noting that “recruiting replacements will be extraordinarily difficult” as doctors leave.
The American Medical Association ducked the abortion issue for years and now sees its members’ professional opinions second-guessed by lawmakers and judges. PhRMA is following the same playbook.
Sarah Varney, a senior correspondent for KHN, joins Ali Rogin of PBS NewsHour to discuss the ruling by a federal judge in Texas that threatens nationwide access to the widely used abortion drug mifepristone, and a separate ruling in Washington state that reached the opposite conclusion.
Since the U.S. Supreme Court reversed federal protections for abortions, medical providers in conservative-led states have been fighting legal and political battles — as well as escalating threats from the anti-abortion movement.
Medicare Advantage, the private plan alternative to traditional Medicare, is embroiled in a growing controversy over whether insurers are being overpaid and what it would mean to reduce those payments. Meanwhile, even as maternal mortality in the U.S. continues to rise, providers of care to pregnant women say they’re leaving states with abortion bans that prevent them from treating pregnancy complications. Margot Sanger-Katz of The New York Times, Jessie Hellmann of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s chief Washington correspondent Julie Rovner to discuss these issues and more.
A U.S. District Court case is being widely followed because the judge’s decision could overturn the FDA’s approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
Any day now a conservative federal judge in Texas could upend the national abortion debate by requiring the FDA to rescind its approval of mifepristone, a drug approved in the U.S. more than 20 years ago that is now used in more than half of abortions nationwide. Meanwhile, a controversial study on masks gets a clarification, although it may be too late to change the public impression of what it found. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
American women are more likely to deliver their babies prematurely than women in most developed countries. It’s a distinction that coincides with high rates of maternal and infant death, billions of dollars in costs, and even lifelong disabilities for the children who survive.
A Donald Trump-appointed federal judge agreed that even the possibility that the father’s daughters might access contraception without his permission violated the tenants of his Christian faith.
Under pressure from Republican attorneys general, the nation's second-largest pharmacy chain says it will not dispense the abortion pill mifepristone.
“What happens in Texas doesn't stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
President Joe Biden’s 2023 State of the Union address leaned heavily on health care issues. Biden took a victory lap for recent accomplishments like capping prescription drug costs for seniors on Medicare. He also urged Congress to make permanent the boosted premium subsidies under the Affordable Care Act, and he sparred with Republicans on threats to cut Social Security and Medicare. Also this week, both sides in the abortion debate are bracing for a court decision out of Texas that could, at least temporarily, make the abortion pill mifepristone illegal nationwide. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kate Baicker of the University of Chicago about a possible middle ground in the effort to get universal health insurance coverage.
The Biden administration this week announced it would let the covid-19 public health emergency lapse on May 11, even as the Republican-led House was voting to immediately eliminate the special authorities of the so-called PHE. Meanwhile, anti-abortion forces are pressuring legislators to both tighten abortion restrictions and pay for every birth in the nation. Margot Sanger-Katz of The New York Times, Rachel Roubein of The Washington Post, and Victoria Knight of Axios join KHN’s chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness about the rollout of the national 988 suicide prevention hotline.
In Part II of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also, for extra credit, the panelists recommend their most memorable reproductive health stories from the last year.
In Part I of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also in this episode, Rovner interviews Elizabeth Nash of the Guttmacher Institute, about changing reproductive policies in the states.
Montana officials are looking to tighten rules around medically necessary abortions for those who use Medicaid as their health insurance. Reproductive health advocates and Democratic lawmakers have said the move is part of a broader agenda to whittle away access to the procedure.
Friday’s annual March for Life rally in Washington, D.C., held for the first time since Roe v. Wade was overturned, signals a new chapter in the anti-abortion movement.
© 2026 KFF